Connect your agent to akta.pro and build company lists like this across sectors and geos.
Private US-headquartered biotech and medical device companies at Series B or later, ranked by total capital raised. Coverage includes neurotechnology, brain-computer interfaces, drug delivery, neuromodulation, surgical devices and precision diagnostics. Data compiled .
| Company | Category | Funding | Products & Services | Expansion Signal | Management |
|---|---|---|---|---|---|
| BrainCo 🇺🇸 Somerville Founded 2015 101-250 employees | Brain-Computer Interface / Neurotechnology Hardware | Funding $1.55B Last raised $286.4M Jan 2026 · Series Unknown | Develops and manufactures non-invasive brain-computer interface hardware that enables neural control of devices, spanning wellness wearables, bionic prosthetics, autism training systems and humanoid robotics components. OxyZen Easleep FocusCalm Intelligent Bionic Hand | New Product Line Demonstrated a mind-controlled bionic hand driven by its non-invasive neural interface. | Han Bicheng Founder & Chief Executive Officer |
| Neuralink 🇺🇸 Austin Founded 2016 101-250 employees | Brain-Computer Interface / Implantable Neurotechnology | Funding $1.34B Last raised Undisclosed May 2026 · Grant (stage not applicable) | Develops fully implantable wireless brain-computer interfaces and a surgical robot that let people with paralysis control computers and devices using neural signals in clinical trials. N1 Implant R1 Robot N1 Charger Neuralink Application | New Product Line Demonstrated brain-controlled activation of an AI assistant, phone calls and dictation in a speech-restoration study participant. | Elon Musk Founder & CEO |
| Imperative Care 🇺🇸 Campbell Founded 2015 501-1000 employees | Neurovascular and Vascular Thrombectomy Medical Devices | Funding $659.0M Last raised $100.0M Mar 2026 · Convertible Note | Develops and commercializes catheter-based thrombectomy systems that remove clots in stroke, pulmonary embolism and limb ischemia, with aspiration technologies cleared by the FDA. Zoom Stroke System Symphony Thrombectomy System Prodigy Thrombectomy System | New Product Line Received FDA clearance for a thrombectomy system treating pulmonary embolism, extending the portfolio beyond stroke. | Farhad Khosravi Chairman and CEO Nick Hopkins Founder and Executive Director Jay Martin Chief Commercial Officer Matthew Garrett Chief Financial Officer |
| Synchron 🇺🇸 Brooklyn Founded 2016 101-250 employees | Implantable Brain-Computer Interface (BCI) Medical Devices | Funding $605.0M Last raised $275.0M Jun 2026 · Series E | Builds a brain-computer interface implanted through the jugular vein that reads motor-intent signals so paralyzed patients can control computers and smart home devices by thought. Stentrode Endovascular Brain-Computer Interface Chiral Cognitive AI Brain Foundation Model | Ecosystem Buildout Unveiled an updated system integrating NVIDIA AI and Apple Vision Pro, letting an ALS patient control an iPad by thought alone. | Tom Oxley Founder and CEO Nicholas Opie Co-founder Riki Banerjee Chief Technology Officer Martin Dieck Chairman |
| Science 🇺🇸 Alameda Founded 2021 101-250 employees | Brain-Computer Interface Medical Devices | Funding $407.3M Last raised $230.0M Mar 2026 · Series C | Develops a wireless subretinal photovoltaic implant that restores central vision in patients with geographic atrophy and builds a broader neuroengineering platform for brain-computer applications. PRIMA Visual Prosthesis Biohybrid Neural Interface Vessel Perfusion Technology Program Science BCI Ecosystem | New Product Line Implanted its vision-restoring retinal chip in the first Stargardt disease patient, extending use beyond age-related macular degeneration. | Max Hodak Founder and CEO Alan Mardinly Co-founder Darius Shahida Chief Strategy Officer Tricia Gugler Chief Financial Officer |
| Precision Neuroscience 🇺🇸 Manhattan Founded 2021 101-250 employees | Brain-Computer Interface Medical Devices | Funding $405.0M Last raised $250.0M Sep 2026 · Series D | Manufactures a non-penetrating thin-film electrode array placed on the brain surface through a minimally invasive micro-slit, using AI software to translate neural activity into commands. Layer 7 Cortical Interface | New Product Line Won FDA 510(k) clearance for its Layer 7 Cortical Interface, the first full regulatory clearance for a next-generation wireless BCI. | Michael Mager Co-Founder and Chief Executive Officer Benjamin Rapoport Co-Founder and Chief Science Officer Demetrios Papageorgiou Co-Founder Mark Hettick Co-Founder & VP of Engineering - Microfabrication |
| Enable Injections 🇺🇸 Cincinnati Founded 2010 101-250 employees | Wearable Drug Delivery Devices | Funding $352.0M Last raised $30.0M Jan 2026 · Corporate Funded | Makes hands-free mechanical on-body injectors that deliver large-volume drugs and biologics subcutaneously, working with pharmaceutical partners to adapt the platform to their therapies. enFuse Wearable Drug Delivery Platform EMPAVELI Injector ASPAVELI enFuse On-Body Delivery System CirCLIQ On-Body Injector | Ecosystem Buildout A pharmaceutical partner's injector built on its technology won approval in Japan to administer a subcutaneous oncology therapy. | Mike Hooven President and CEO David Kroekel Chief Operating Officer Tim Flaherty Executive Vice President and Chief Financial Officer Matt Huddleston Executive Vice President and Chief Commercial Officer |
| Cala Health 🇺🇸 San Mateo Founded 2014 101-250 employees | Wearable Neuromodulation Therapy Devices | Funding $298.3M Last raised $50.0M Apr 2026 · Debt Funded | Sells FDA-cleared wrist-worn devices delivering patterned peripheral nerve stimulation that temporarily relieves hand tremor in adults with essential tremor and Parkinson's disease. Cala kIQ System Cala kIQ Plus Cala Trio Replacement Stimulator Bands | New Product Line Rolled out a next-generation wearable nationwide in the US with three stimulation modes and per-session calibration. | Deanna Harshbarger Chief Executive Officer Kate Rosenbluth, PhD President & Chief Innovation Officer Kevin Strange Chief Financial Officer Stacy Enxing Seng Chairwoman of the Board |
| Monteris Medical 🇺🇸 Minnetonka Founded 1999 101-250 employees | Minimally Invasive Neurosurgical Devices | Funding $279.1M Last raised $28.0M Mar 2026 · Series E | Sells a robotic MR-guided laser ablation platform for minimally invasive brain surgery, delivering interstitial thermal therapy to treat brain tumors, radiation necrosis and drug-resistant epilepsy. NeuroBlate System NeuroBlate NB3 FullFire 1.6mm Laser Probe NeuroBlate FullFire Laser Probe NeuroBlate SideFire Laser Probe | New Product Line Won a new FDA 510(k) clearance for the NeuroBlate System in April 2026. | Martin J. Emerson President and Chief Executive Officer Doug Pahr Chief Financial Officer Lisa Hayden Senior Vice President, Market Access and Chief Compliance Officer |
| Route 92 Medical 🇺🇸 San Mateo Founded 2015 11-50 employees | Neurovascular Medical Devices | Funding $271.5M Last raised $50.0M Apr 2026 · Private Equity Round | Develops catheter-based neurovascular intervention devices for treating acute ischemic stroke, including catheter systems with proprietary delivery technology and an FDA-cleared reperfusion system. FreeClimb 54 Catheter System | Funding Signal Entered a senior secured debt facility with a specialist lender to support its neurovascular catheter platform. | Tony Chou Founder, President & CEO Joey English Co-founder & Chief Medical Officer Kirsten Valley Chief Operating Officer |
| GT Medical Technologies 🇺🇸 Tempe Founded 2017 101-250 employees | Radiation Therapy Medical Devices | Funding $262.5M Last raised $100.0M Jun 2026 · Series E | Manufactures a bioresorbable collagen tile embedded with cesium-131 radiation seeds, implanted during brain tumor surgery to deliver immediate targeted radiation therapy to the resection cavity. GammaTile GammaTile Commitment Pledge ROADS Phase 3 Clinical Trial GammaTile Centers of Excellence Program | Ecosystem Buildout Designated a New York academic medical center as a Center of Excellence for its brain tumor radiation implant. | Per Langoe Chief Executive Officer David G. Brachman, MD, FASTRO Co-Founder and Chief Technology Officer Heyoung McBride, MD, MS, FASTRO Co-Founder Peter Nakaji, MD Co-Founder |
| Neuros Medical 🇺🇸 Arden Hills Founded 2017 11-50 employees | Implantable Neurostimulation Medical Devices | Funding $204.7M Last raised $35.0M Mar 2026 · Debt Funded | Sells an implantable electrical nerve stimulation system using a cuff electrode to treat chronic intractable phantom and residual pain in adult lower-limb amputees. Altius | Funding Signal Secured a $35M growth capital facility from Trinity Capital to scale commercialization of Altius and enter new markets. | — |
| CereVasc 🇺🇸 Boston Founded 2014 11-50 employees | Neurological Medical Devices | Funding $199.0M Last raised $85.0M Jun 2026 · Series C | Develops an endovascular shunt delivered through a leg vein under X-ray guidance to drain cerebrospinal fluid, treating hydrocephalus without invasive neurosurgery. eShunt® System Generation 2 eShunt System Follow-on Products | Ecosystem Buildout Opened a manufacturing and research facility in Massachusetts to support assembly, testing and production of its implantable shunt. | Dan Levangie Chairman and CEO Dr. Carl Heilman Co-founder Patrick Sullivan Co-founder Dr. Adel Malek Chief Medical Officer |
| Bridge to Life Ltd. 🇺🇸 Duluth Founded 2024 51-100 employees | Organ Preservation Medical Devices | Funding $167.5M Last raised $110.0M Aug 2026 · Series C | Supplies organ preservation and perfusion solutions for transplantation, including a hypothermic oxygenated perfusion machine, cold storage and machine perfusion solutions and related disposables. VitaSmart™ Hypothermic Oxygenated Perfusion System Belzer UW® Cold Storage Solution Belzer MPS® UW Machine Perfusion Solution EasiSlush® Sodium Chloride Solution | Ecosystem Buildout UK health technology body recommended routine NHS funding for its liver perfusion system. | Don Webber President and Chief Executive Officer Brian Lenz Chief Financial Officer David Castiglioni Chief Commercial Officer Stevan Schweighardt Chairman |
| Calyxo 🇺🇸 Pleasanton Founded 2016 251-500 employees | Urology Medical Devices | Funding $165.4M Last raised $40.0M Apr 2026 · Series F | Makes an all-in-one device for kidney stone treatment that combines ureteroscopy, laser lithotripsy, irrigation, vacuum aspiration and stone collection in a single steerable instrument. CVAC System SURE Procedure CVAC Image Processor Software | New Product Line Launched a second-generation stone-removal system with a reverse deflection mode letting urologists choose between standard and reverse deflection. | Joe Catanese III, PhD President and Chief Executive Officer Jee Shin Founder and Chief Business Officer Doug Hughes Chief Financial Officer |
A company qualifies when it builds a medical device that interfaces directly with biology or the human body: neural interfaces, implantable and wearable neuromodulation, vascular and neurovascular devices, drug-delivery hardware, organ preservation systems and implanted radiation therapy.
The list separates these biology-facing devices from software, diagnostics, consumer wellness products, imaging equipment, surgical robots and cell therapies that share the same akta.pro industry code. Across the 15 companies the largest segment by capital is brain-computer interfaces, with $4.31B raised by five companies.
The 15 companies have raised $7.16B in total, and the top three account for $3.55B, or 49.5% of that amount.
Out of scope: public companies, digital therapeutics and imaging software, consumer wearables, diagnostics, surgical robotics and imaging or radiosurgery equipment, cell therapies, veterinary devices, and any company whose latest round predates 2026 or is below Series B.
Companies are tagged against standard industry codes and against akta.pro's internal taxonomy, so the same set can be rebuilt by code, by segment, or by a combination of both.
NAICS 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing 339112 Surgical and Medical Instrument Manufacturing 339113 Surgical Appliance and Supplies Manufacturing SIC 3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS 3845 ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS 3842 ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES Internal taxonomy HLAH Medical Devices & DiagnosticsIndustry codes are provided for cross-referencing against public filings and procurement records. akta.pro classification is independent of them, so a company may carry an internal segment without a matching NAICS or SIC registration.